AI-POWERED NEWS

30+ sources. Zero spin.

Cross-referenced, unbiased news. Both sides of every story.

← Back to headlines

Cornell's Baby Heart Device Is Back. The Months It Lost Aren't.

Cornell's Baby Heart Device Is Back. The Months It Lost Aren't.
The Trump administration froze $250 million in Cornell research grants in April 2025 as leverage over campus DEI and antisemitism disputes. One of those grants was funding a potentially life-saving artificial heart for infants. Cornell made a deal, the money came back — but the damage to the research timeline is real and possibly permanent.

A Device the Size of a AA Battery. Stakes the Size of a Life.

James Antaki has spent over 20 years building a heart pump small enough to fit inside a baby's chest. It's called the PediaFlow. About the size of a AA battery. Designed to keep infants with congenital heart defects alive long enough to reach surgery — or a transplant.

According to Cornell University's own reporting, approximately 40,000 children are born every year in the U.S. with some type of heart condition. About 1 in 100 children has a congenital heart defect. The FDA has officially identified this as an area of critical medical device need.

Private companies won't build it. The patient population isn't big enough to generate profit. So federal research grants exist precisely for this — to fund the work the market won't.

Antaki had secured a $6.5 million, four-year Department of Defense grant to take the PediaFlow through final manufacturing and into human clinical trials. According to Cornell Chronicle, the DoD formally accepted the proposal on March 30, 2025. One week later, the funding was gone.

How a Campus Politics Fight Killed a Baby Heart Grant

The Trump administration didn't cancel Antaki's grant because of anything Antaki did. It canceled it as part of a sweeping freeze on roughly $250 million in Cornell federal funding — itself part of a broader crackdown targeting elite universities over DEI programs and alleged failures to address antisemitism on campus.

According to NPR, approximately $10 billion in total grants were canceled across multiple institutions.

Antaki told NPR bluntly: "We feel like collateral damage. There is no reason to punish us. We're trying to do good in the world."

His research has nothing to do with campus ideology disputes. The PediaFlow isn't a DEI program. It's biomedical engineering funded by the Department of Defense because portable pediatric heart support doesn't exist yet and kids are dying without it.

Existing technology requires children to be tethered to a refrigerator-sized hospital compressor. The PediaFlow would let them go home.

What Mainstream Coverage Is Getting Wrong

Left-leaning outlets like NPR have covered this story with appropriate detail — but they've framed it almost entirely as an indictment of the Trump administration, with little acknowledgment that Cornell's own institutional behavior triggered the confrontation in the first place.

Right-leaning outlets have largely ignored the story. A government funding freeze that halted life-saving pediatric research deserves coverage regardless of which administration ordered it. Fiscal conservatives who rightly despise government waste should recognize when the government is failing to fund something it uniquely needs to fund.

Research grants weaponized as political leverage hurt patients, not administrators. The Cornell provosts and DEI coordinators who created the conditions for this fight kept their jobs throughout. Antaki's team almost didn't survive it.

The Deal — and What It Cost

According to NPR, Cornell became the third elite university to cut a deal with the White House. The terms: Cornell formally accepts the administration's interpretation of civil rights law, pays the federal government $30 million, and commits to $30 million in agricultural investment over three years. In exchange, the roughly $250 million in frozen grants — including Antaki's — were restored.

The grants came back. The months didn't.

Antaki told NPR the rebuilding process is "daunting." Staff were let go. Momentum was lost. Years of preparation for clinical trials were disrupted. Cornell Chronicle quoted him warning earlier that if the interruption lasted long enough, the damage would be "irreversible."

It lasted long enough to do damage. Whether it's irreversible is still an open question.

A 4-Year-Old in Philadelphia Named Caleb

While this was playing out in Washington and Ithaca, a 4-year-old named Caleb Strickland was sitting in a room on the sixth floor of Children's Hospital of Philadelphia eating a blue popsicle with a failing heart. His mother, Nora Strickland, told NPR she feels "far away" from the administration's disputes with universities.

The people hurt by bureaucratic power plays are almost never the people the power play is aimed at.

What Comes Next

The Trump administration had legitimate grievances with how universities like Cornell were running DEI programs and handling antisemitism complaints. Those grievances deserved to be addressed.

Freezing pediatric cardiac research funding to pressure a university's general counsel is a wrecking ball where a scalpel was needed. Real children — kids like Caleb — are downstream of those decisions.

The deal is done. The grants are back. Cornell's lawyers and administrators negotiated their way through it.

James Antaki just wants to finish building a heart pump that fits in your pocket and keeps babies alive.

Seven months were lost. In medicine, that cost doesn't show up on a balance sheet — it shows up in a waiting room.

Sources

center-left npr Deal restores Cornell's federal grants, reviving research on infant artificial heart : NPR
left NYT How a Funding Pause Derailed an Artificial Heart for Babies
unknown news.cornell.edu Research at risk: Life-saving heart pumps for babies | Cornell Chronicle
unknown kgou This 4-year-old's heart is failing. A federal grant that might help him was canceled | KGOU - Oklahoma's NPR Source